The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.

Authors:
Address: Malaria Public Health and Epidemiology Group, KEMRI/Wellcome Trust Research Programme, PO Box 43640, 00100 GPO Nairobi, Kenya.
Journal:


Publication:
Free Text: The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.

abstract

BACKGROUND:

health facility stock-outs of artemeTher-lumefantrine (AL), the common first-line therapy for uncomplicated malaria across Africa, adversely affect effective malaria case-management. They have been previously reported on various scales in time and space, however the magnitude of the problem and trends over time are less clear. Here, 2010-2011 data are reported from public facilities in Kenya where alarming stock-outs were revealed in 2008.

METHODS:

Data were collected between January 2010 and June 2011 as part of 18 monthly cross-sectional surveys undertaken at nationally representative samples of public health facilities. The primary monitoring indicator was total stock-out of all four weight-specific AL packs. The secondary indicators were stock-outs of at least one AL pack and individual stock-outs for each AL pack. Monthly proportions and summary means of the proportions over the monitoring period were measured for each indicator. Stock-out trends were assessed using linear regression.

RESULTS:

The number of surveyed facilities across 18 time points ranged between 162 and 176 facilities. The stock-out means of the proportion of health facilities were 11.6% for total AL stock-out, 40.6% for stock-out of at least one AL pack, and between 20.5% and 27.4% for stock-outs of individual AL packs. Monthly decrease of the total AL stock-out was 0.005% (95% CI: -0.5 to +0.5; p = 0.983). Monthly decrease in the stock-out of at least one AL pack was 0.7% (95% CI: -1.5 to +0.3; p = 0.058) while stock-outs of individual AL packs decreased monthly between 0.2% for AL 24-pack and 0.7% for AL six-pack without statistical significance for any of the weight-specific packs.

CONCLUSIONS:

Despite lower levels of AL stock-outs compared to the reports in 2008, the stock-outs at Kenyan facilities during 2010-2011 are still substantial and of particular worry for the most detrimental:- simultaneous absence of any AL pack. Only minor decrease was observed in the stock-outs of individual AL packs. Recently launched interventions to eliminate AL stock-outs in Kenya are fully justified.



Related Articles
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
East Afr Med J. 2008
Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.
Njogu J, Akhwale W, Hamer DH, Zurovac D. East Afr Med J. 2008 May; 85(5):213-21.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program. Rep Carcinog Backgr Doc. 2008 Sep; (8-5978):i-398.
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.
Am J Trop Med Hyg. 2009
Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.
Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW. Am J Trop Med Hyg. 2009 May; 80(5):737-8.
Review Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.
Malar J. 2009
Review Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.
Barnes KI, Chanda P, Ab Barnabas G. Malar J. 2009 Oct 12; 8 Suppl 1:S8. Epub 2009 Oct 12.
Review Artemisinin-based combination therapy for treating uncomplicated malaria.
Cochrane Database Syst Rev. 2009
Review Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD007483. Epub 2009 Jul 8.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.